Drug application
BRIVARACETAM (BRIVARACETAM)
Drugs@FDA ANDA 219766 · SHANDONG
Key facts
| Drug name | BRIVARACETAM |
|---|---|
| Active ingredients | BRIVARACETAM |
| Application type | ANDA |
| Application number | 219766 |
| Company | SHANDONG |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 50MG/5ML (10MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jul 13, 2026 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.